A study assessing Boston Scientific's (Natick, Massachusetts) EZ FilterWire to catch bits of plaque and blood clot that break loose during percutaneous coronary intervention (PCI) in patients with acute coronary syndrome has been discontinued after it failed to show that it can reduce rates of major cardiovascular complications.

Business developments

Name: Relias Media
Price range: $

January 2, 2015

Reprints

Recognizing, Managing, and Reporting Pediatric Sexual Abuse and Assault
Eleventh Circuit Affirms Jury Verdict of $2.5 Million for Mesh Device Plaintiff Despite Close Call on Statute of Limitations
Indiana Appellate Court Allows Case to Proceed Against Doctor Accused of Improperly Accessing Patients’ Medical Records
Malpractice Insurance Rates Increasing After Stable Period
Clinical Decision Software Highly Effective in OR